Our study suggested that KEAP1 and STK11 shared common mechanism in immune regulation, which is associated with enhancement of redox phenotype and the subsequent inhibition of STING/MDA5 expression and the downstream interferon signaling in cancer cells. The gene discussed is STK11; the disease is cancer.